AL
EGRX

AJO LP’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

AJO LP’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-97,755
Closed -$4.15M – 667
2020
Q3 		$4.15M Sell
97,755
-40,731
-29% -$1.78M 0.04% 287
2020
Q2 		$6.64M Sell
138,486
-7,271
-5% -$363K 0.06% 236
2020
Q1 		$6.7M Sell
145,757
-22,106
-13% -$1.11M 0.06% 215
2019
Q4 		$10.1M Sell
167,863
-8,884
-5% -$530K 0.06% 216
2019
Q3 		$10M Sell
176,747
-11,621
-6% -$654K 0.06% 220
2019
Q2 		$10.5M Buy
188,368
+103,276
+121% +$5.39M 0.05% 221
2019
Q1 		$4.3M Sell
85,092
-17,241
-17% -$767K 0.02% 352
2018
Q4 		$4.12M Buy
102,333
+31,373
+44% +$1.62M 0.02% 341
2018
Q3 		$4.92M Buy
+70,960
New +$5.38M 0.02% 361
2018
Q1 		– Sell
-63,577
Closed -$3.4M – 690
2017
Q4 		$3.4M Sell
63,577
-51,320
-45% -$2.86M 0.01% 379
2017
Q3 		$6.85M Buy
114,897
+35,776
+45% +$2.16M 0.03% 283
2017
Q2 		$6.24M Buy
79,121
+69,674
+738% +$5.7M 0.03% 282
2017
Q1 		$784K Buy
+9,447
New +$702K ﹤0.01% 449
2015
Q3 		– Sell
-47,340
Closed -$3.83M – 561
2015
Q2 		$3.83M Buy
+47,340
New +$3.08M 0.02% 335

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

AJO LP's EGRX Position: Q4 2020 in Review

AJO LP sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2020, closing a stake of 97,755 shares — an estimated $4.15M sold.

AJO LP first reported a position in EGRX in Q2 2015 and held it in 14 quarters. The position peaked at $10.5M in Q2 2019. 166 funds tracked by Wall St. Rank hold EGRX as of Q4 2020.

  • AJO LP reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 97,755 Eagle Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.15M.
  • AJO LP first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 14 quarters.
  • AJO LP's Eagle Pharmaceuticals, Inc. position peaked at $10.5M in Q2 2019.
  • 166 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.